rs199643287
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBS2_Supporting
The NM_022552.5(DNMT3A):c.131C>T(p.Thr44Met) variant causes a missense change. The variant allele was found at a frequency of 0.000049 in 1,612,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_022552.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNMT3A | ENST00000321117.10 | c.131C>T | p.Thr44Met | missense_variant | Exon 3 of 23 | 1 | NM_022552.5 | ENSP00000324375.5 | ||
DNMT3A | ENST00000264709.7 | c.131C>T | p.Thr44Met | missense_variant | Exon 3 of 23 | 1 | ENSP00000264709.3 | |||
DNMT3A | ENST00000406659.3 | c.131C>T | p.Thr44Met | missense_variant | Exon 3 of 4 | 1 | ENSP00000384852.3 | |||
DNMT3A | ENST00000380756.7 | n.131C>T | non_coding_transcript_exon_variant | Exon 3 of 24 | 1 | ENSP00000370132.3 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152166Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000963 AC: 24AN: 249336Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135044
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1460548Hom.: 0 Cov.: 31 AF XY: 0.0000495 AC XY: 36AN XY: 726694
GnomAD4 genome AF: 0.000131 AC: 20AN: 152284Hom.: 0 Cov.: 31 AF XY: 0.000134 AC XY: 10AN XY: 74458
ClinVar
Submissions by phenotype
DNMT3A-related disorder Uncertain:1
The DNMT3A c.131C>T variant is predicted to result in the amino acid substitution p.Thr44Met. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.075% of alleles in individuals of East Asian descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Tatton-Brown-Rahman overgrowth syndrome Benign:1
- -
not specified Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at